Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2020-10-06 Earnings Release
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
Predilife : résultats semestriels 2020
Earnings Release Classification · 1% confidence The document is titled "PrediLife : résultats semestriels 2020" (PrediLife: Half-year results 2020) and presents selected financial information for the first semester ending June 30, 2020, including revenue, operating expenses, and net results compared to the previous year. It also discusses business updates, capital increases, and post-closing events. This structure—a press release announcing comprehensive financial figures for a period shorter than a year (semestriels/half-year)—is characteristic of an Interim/Quarterly Report (IR). It is not just an Earnings Release (ER) as it contains detailed financial tables and operational context, nor is it the full Annual Report (10-K). H2 2020
2020-10-06 French
PrediLife : lancement de la réservation par internet de la consultation de prévention de cancer du sein
Regulatory Filings Classification · 1% confidence The document is a press release dated October 1, 2020, announcing the launch of an internet reservation service for breast cancer prevention consultations by PrediLife. It details a new service offering, market potential, and contact information. This type of announcement, which is a general corporate update or news release that doesn't fit the specific categories like 10-K, ER, or DIV, is best classified as a general Regulatory Filing (RNS) or potentially a miscellaneous announcement. Given the options, RNS serves as the appropriate fallback for general corporate news releases that are not earnings, capital changes, or management changes. It is not a formal financial report (like 10-K or IR) nor a specific announcement like a dividend or director dealing.
2020-10-01 French
Predilife annonce le versement d'un montant de 1ME de la part de BPI
Capital/Financing Update Classification · 1% confidence The document announces a specific financial event: the receipt of a 1M Euro loan (PGE - Prêt Garanti par l'État) from BPI France. This action directly relates to the company's fundraising, financing activities, and capital structure consolidation. This aligns perfectly with the definition of 'Capital/Financing Update' (Code: CAP). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific financing transaction.
2020-07-30 French
Bilan semestriel du contrat de liquidité contracté avec TSAF - Tradition Securities and Futures (juin 2020)
Regulatory Filings Classification · 1% confidence The document is titled "Bilan semestriel au 30 Juin 2020 du contrat de liquidité contracté avec TSAF – Tradition Securities and Futures" (Semi-annual balance sheet as of June 30, 2020, for the liquidity contract with TSAF). It provides a detailed summary of the liquidity contract status, including the assets held (shares and cash) as of the reporting date (June 30, 2020), transactions executed during the first half of 2020 (S1 2020), and a detailed daily transaction log. This content strongly indicates a periodic financial/operational report covering an interim period (six months). This aligns best with the definition of an Interim / Quarterly Report (IR), as it is a comprehensive report for a period shorter than a year, even though its specific focus is on the liquidity contract rather than the entire company's operations/P&L. It is not a general Earnings Release (ER) which is usually just highlights, nor is it the full Annual Report (10-K). Since it details the results for a specific interim period (H1 2020), IR is the most appropriate classification.
2020-07-16 French
Predilife annonce la réalisation d'une augmentation de capital par voie de placement privé pour un montant de 1, 7 M d'euros
Capital/Financing Update Classification · 1% confidence The document is a press release titled "PREDILIFE ANNONCE LA RÉALISATION D'UNE AUGMENTATION DE CAPITAL PAR VOIE DE PLACEMENT PRIVÉ POUR UN MONTANT DE 1,7 M€" (PREDILIFE ANNOUNCES THE COMPLETION OF A CAPITAL INCREASE VIA PRIVATE PLACEMENT FOR AN AMOUNT OF €1.7M). The content details the issuance of new ordinary shares, the amount raised (€1.7 million), the price per share (€7.00), the resulting change in share capital structure, and mentions compliance with French financial regulations (Code monétaire et financier, AMF). This clearly describes a corporate financing activity, specifically a capital increase/fundraising event. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on the financing transaction.
2020-02-28 French
Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote_janvier 2020
Share Issue/Capital Change Classification · 1% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et du nombre total de droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights). It explicitly states the number of shares and voting rights as of a specific date (January 31, 2020) and references French regulatory articles (AMF). This type of regular disclosure regarding the total number of shares and voting rights is a specific regulatory requirement, often related to capital structure changes or major shareholdings. While it touches upon capital structure, the primary focus is the official count of shares/votes. This aligns best with 'Share Issue/Capital Change' (SHA) or potentially 'Major Shareholding Notification' (MRQ) if it were about changes in ownership thresholds, but since it's a mandatory monthly disclosure of the total count, it relates directly to the capital structure itself. Given the options, 'SHA' (Share Issue/Capital Change) is the closest fit for a formal disclosure of the total share count, although 'MRQ' (Major Shareholding Notification) is also plausible if interpreted broadly as capital structure monitoring. However, since it is a formal announcement of the total share count, which is a fundamental component of capital structure, SHA is selected. If a more specific 'Share Capital Disclosure' existed, it would be preferred. Given the available codes, SHA is the most appropriate classification for a formal disclosure of the total share count.
2020-02-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.